Boston, MA 10/14/2014 (wallstreetpr) – According to reports, Biocept Inc (NASDAQ:BIOC) and Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) have decided to adjoin hands for evaluating micro-RNAs from divergent circulating tumor cells. BIOC is one of the well-known molecular oncology diagnostics companies and specializes in circulation of tumor cells and biomarker analysis of cell-free circulating tumor DNA. At the same time, ROSG is a known molecular diagnostics company and focuses upon micro-RNA-based diagnostics on the basis of various world-class proprietary micro-RNA platform technologies.
Insights of the matter:
Biocept Inc (NASDAQ:BIOC) and ROSG have decided to come together in order to evaluate various aspects of micro-RNAs. Their main focus of both the companies is on developing an innovative approach towards cancer diagnosis. As a result of this collaboration, micro-fluidic channel technology of BIOC will be used for capturing circulating tumor cells and then technical expertise of Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) will be applied for extracting and analyzing micro-RNAs from these cells. Both the companies will test the markers used by ROSG and also look for new markers.
With the help of this combined study, both the companies will look forward to determining if the CTCs from lung cancer have same micro-RNA signature like previously demonstrated ones through CLIA laboratory of Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG). Micro-fluidic channel technology of BIOC will be used for capturing CTCs in the blood. After it, the RT-PCR platform of Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) will be deployed to isolate those micro-RNAs from CTCs. The main objective of executing this joint project is to demonstrate the basic concept and find out various opportunities for future development. It can result in the development of certain technologies for next generation tests, which would focus on using CTCs from blood as liquid biopsies. Management and development teams of both the companies seem very happy after this collaboration and hope that it will result in the development of various modern era theories, concepts and tests.
